Related by context. All words. (Click for frequent words.) 76 comorbid conditions 75 comorbidities 66 comorbidity 65 morbidities 63 macrovascular disease 63 lipid abnormalities 63 dopaminergic therapy 62 T2DM 62 renal dysfunction 62 OAB symptoms 62 atherothrombosis 62 hypertension diabetes mellitus 62 potentially modifiable 61 macrovascular events 61 nonalcoholic steatohepatitis 61 lipid disorders 61 diabetes mellitus 61 metabolic parameters 61 hyperglycaemia 61 myeloproliferative neoplasms 61 coronary revascularization procedures 60 prognostic variables 60 hypertension 60 comorbid 60 cardiometabolic risk 60 thrombophilia 60 renal impairment 60 psychiatric comorbidities 60 lipohypertrophy 60 psychiatric comorbidity 60 renal insufficiency 60 hepatorenal syndrome 60 cardiovascular disease hypertension 60 concomitant medications 60 ischemic cardiomyopathy 60 decompensated heart failure 59 antidiabetic drugs 59 atherogenic dyslipidemia 59 microvascular complications 59 Sleep disordered breathing 59 diabetes mellitus DM 59 comorbid depression 59 comorbid psychiatric 59 ADHF 59 immunosuppressive therapies 59 glycated hemoglobin levels 59 modifiable risk 59 predisposing factors 59 thromboprophylaxis 59 stable angina 59 macroalbuminuria 59 dyslipidemia 59 chronic thromboembolic pulmonary 59 autonomic dysfunction 59 elevated triglyceride levels 59 dyslipidaemia 59 metabolic abnormalities 59 systolic hypertension 59 coronary artery disease 59 HIV HCV coinfected 59 HRQL 59 ATACAND 59 microalbuminuria 59 abnormal lipids 59 warfarin therapy 59 inflammatory biomarkers 59 UA NSTEMI 58 Primary IGFD 58 pulmonary exacerbations 58 neurocognitive deficits 58 unfavorable cytogenetics 58 aortic valve stenosis 58 postoperative pulmonary 58 NAFLD 58 antihypertensive therapy 58 metabolic disturbances 58 androgen deficiency 58 antihypertensive drugs 58 post thrombotic syndrome 58 HSCT 58 macrovascular complications 58 systolic dysfunction 58 proliferative diabetic retinopathy 58 β blockers 58 tumor histology 58 postoperative infections 58 relapsed SCLC 58 revascularization procedures 58 dyslipidemias 58 myocardial ischemia 58 IPAH 58 subclinical hypothyroidism 58 pharmacologic intervention 58 hemodialysis patients 58 lipid lowering agents 58 CTEPH 58 diabetes dyslipidemia 58 confounding variables 58 hyperkalemia 58 hypertensives 58 carotid stenosis 58 pathologic fractures 58 T1DM 58 DVT PE 58 postoperative AF 58 adverse cytogenetics 58 MetS 58 chronic metabolic acidosis 58 preserved ejection fraction 58 depressive symptomatology 58 lipid parameters 58 glucocorticoid therapy 58 severely immunosuppressed 58 NATRECOR ® 58 adrenalectomy 58 perioperative complications 57 sociodemographic factors 57 neuropsychiatric symptoms 57 urinary symptoms 57 morbidity mortality 57 obstructive CAD 57 neovascular glaucoma 57 comorbid disorders 57 atherosclerotic disease 57 LV dysfunction 57 paroxysmal AF 57 hypoglycemic events 57 oral anticoagulation 57 primary aldosteronism 57 acetabular dysplasia 57 APOE genotype 57 therapeutic regimens 57 nonalcoholic steatohepatitis NASH 57 AGILECT R 57 lupus nephritis 57 metformin Glucophage 57 juvenile idiopathic arthritis 57 microvascular disease 57 cirrhotic patients 57 rheumatologic 57 EGFR mutation status 57 HbA1c levels 57 LUTS 57 cardio metabolic 57 somatic symptoms 57 diabetic kidney 57 anticholinergic medications 57 TNF antagonist 57 serum calcium levels 57 beta blocker therapy 57 levodopa therapy 57 overt nephropathy 57 impaired cognition 57 postoperative mortality 57 SHPT 57 antiarrhythmic drug 57 antiplatelet medications 57 prognostic factors 57 HRQoL 57 hypoxemia 57 unstable angina UA 57 cSSSIs 57 carotid IMT 57 artery stenosis 57 ICD shocks 57 Cognitive impairment 57 hyperoxaluria 57 antihypertensive medications 57 NATRECOR R 57 prescribe statins 57 hereditary predisposition 57 neurologic complications 57 acute coronary syndromes 57 improves glycemic 57 dosage regimens 57 neurologic sequelae 57 thromboembolic disease 57 angiographically 57 IV NSCLC 57 pericardial effusion 57 fragility fracture 57 hypovitaminosis D 57 EXJADE 57 hypertension dyslipidemia 57 HRQOL 57 severe hypoglycaemia 57 nonoperative treatment 57 antithrombotic therapy 56 fragility fractures 56 obstructive coronary artery 56 chronic diseases 56 hypercholesterolaemia 56 renal artery stenosis 56 thromboembolic complications 56 atherothrombotic 56 symptomatic hyponatremia 56 hyperlipidaemia 56 hyperglycemia 56 heparin induced thrombocytopenia 56 Subgroup analyzes 56 Pseudomonas aeruginosa infections 56 underlying pathophysiology 56 NYHA Class II 56 venous thromboembolic disease 56 distant metastases 56 adenomatous polyps 56 Boden Albala 56 left ventricular dysfunction 56 comorbid illnesses 56 chronic renal insufficiency 56 variceal bleeding 56 asplenia 56 organ dysfunction 56 atherothrombotic disease 56 perioperative mortality 56 pacemaker implantation 56 uncontrolled hypertension 56 elevated triglycerides 56 oral antidiabetic agents 56 femoral neck fracture 56 platelet reactivity 56 asthma exacerbations 56 immunosuppressive regimens 56 symptomatic VTE 56 nondiabetic patients 56 bowel resection 56 COPD asthma 56 noncardiovascular mortality 56 elevated IOP 56 occlusive disease 56 postoperative atrial fibrillation 56 antiarrhythmic medications 56 vascular dysfunction 56 serum phosphate levels 56 geriatric syndromes 56 acute myocardial infarction MI 56 unmeasured confounders 56 sleep disordered breathing 56 isolated systolic hypertension 56 postoperative delirium 56 hyperbilirubinemia 56 hemorrhagic complications 56 Exacerbations 56 myeloproliferative disorders 56 FFR measurements 56 pulmonary hypertension PH 56 psychosocial functioning 56 chronic GVHD 56 cardiovascular comorbidities 56 lipid lowering therapy 56 psychosocial variables 56 severe hypoglycemia 56 POAG 56 thoracoscopic lobectomy 56 prostate cancer CaP 56 electrolyte abnormalities 56 APTIVUS r 56 atrial arrhythmias 56 thrombotic complications 56 intracranial hemorrhage ICH 56 severe aortic stenosis 56 LVNC 56 ALT flares 56 ulcer healing 56 pathophysiologic 56 thromboembolic 56 antiplatelet drugs 56 juvenile idiopathic arthritis JIA 56 multivessel disease 56 lipid lowering therapies 56 TEAEs 56 ICD implantation 56 pulmonary artery hypertension 56 Pulmonary hypertension 56 elevated fasting glucose 56 haematologic 56 cranial irradiation 56 hyperparathyroidism 56 dysglycemia 56 G6PD deficiency 56 Excessive daytime sleepiness 56 subclinical atherosclerosis 56 postoperative morbidity 56 diabetic microvascular complications 55 extrapyramidal symptoms EPS 55 HBV infection 55 HbA1C levels 55 diabetic polyneuropathy 55 Venous thromboembolism 55 nonvertebral fracture 55 immunosuppressive medications 55 coinfected patients 55 NYHA class 55 insulin resistance syndrome 55 adjuvant therapies 55 Eisenmenger syndrome 55 hyperlipidemia 55 antiplatelet agents 55 diabetes mellitus hypertension 55 inhaled corticosteroid therapy 55 renal transplantation 55 nonfasting triglyceride levels 55 Chronic pancreatitis 55 anticoagulation therapy 55 VTE prophylaxis 55 uncontrolled asthma 55 resistant hypertension 55 MGUS 55 familial clustering 55 diabetes mellitus T2DM 55 acute coronary syndromes ACS 55 HBeAg negative 55 abnormal glucose tolerance 55 serum PTH 55 abnormal lipid 55 pretransplant 55 loop diuretics 55 metastatic malignant melanoma 55 lipid levels 55 progressive dyspnea 55 onset diabetes mellitus 55 nonischemic 55 GERD symptoms 55 thrombolytic agents 55 refractory angina 55 elevated LDH 55 Severe Primary IGFD 55 pharmacological approaches 55 Hurthle cell 55 heterozygous FH 55 thromboembolic events 55 subgroup analyzes 55 cardiovascular morbidity 55 postoperative complication 55 subclinical hyperthyroidism 55 coagulation abnormalities 55 cerebrovascular events 55 primary hyperparathyroidism 55 abdominal adiposity 55 Generalized anxiety disorder 55 decompensation 55 hypertension hypercholesterolemia 55 corticosteroid therapy 55 NNT = 55 cardiovascular mortality 55 neurologic symptoms 55 thyroid dysfunction 55 sociodemographic characteristics 55 cancer cachexia 55 extrapyramidal symptoms 55 Aortic stenosis 55 underdiagnosis 55 Genetic variants 55 perioperative morbidity 55 cardiac biomarkers 55 alcoholic fatty liver 55 hypoglycemic episodes 55 antihypertensive medication 55 SIADH 55 diabetic retinopathy DR 55 diabetes cardiovascular disease 55 colorectal adenoma 55 nonvertebral fractures 55 mixed hyperlipidemia 55 pharmacological therapies 55 impaired glucose tolerance 55 chronicity 55 coexisting illnesses 55 metastatic disease 55 debilitating complication 55 diabetes 55 hypocalcemia 55 invasive fungal infections 55 vasomotor symptoms 55 torsade de pointes 55 antibiotic prophylaxis 55 untreated OSA 55 nonadherence 55 chorioamnionitis 55 myopathy rhabdomyolysis 55 Uncontrolled hypertension 55 LTBI 55 clinically meaningful improvements 55 systemic lupus erythematosus 55 cryptogenic stroke 55 acute coronary syndrome 55 covariates 55 gestational diabetes mellitus 55 overactive bladder symptoms 55 rheumatic disease 55 microbleeds 55 comorbid anxiety 55 multisystem disease 55 vertebral fractures 55 elevated CRP 55 hypervolemic hyponatremia 55 glycosylated hemoglobin levels 55 multi factorial diseases 55 lactic acidosis 55 inhaled glucocorticoids 55 liver histology 55 Erythropoietic therapies may 55 polyp recurrence 55 dyslipidemia hypertension 55 lower extremity amputation 54 hemodynamics 54 reflux symptoms 54 genetic syndromes 54 serum phosphate 54 lupus erythematosus 54 obstructive sleep apnea 54 Wernicke encephalopathy 54 serum triglyceride levels 54 chronic myocardial ischemia 54 lipid profiles 54 recurrent ischemia 54 adenotonsillectomy 54 immunomodulatory therapy 54 rheumatic diseases 54 acromegalic patients 54 radiotherapy RT 54 neurocognitive function 54 CMV disease 54 potential confounders 54 vascular disease 54 immune reconstitution syndrome 54 Acute Myeloid Leukaemia AML 54 SLNB 54 fasting plasma glucose 54 unfavorable prognostic 54 hypersomnia 54 recurrent DVT 54 pemphigus 54 thrombotic events 54 bosentan 54 underwent angiography 54 elevated LDL cholesterol 54 carotid atherosclerosis 54 poststroke 54 hypertensive patients 54 Charlson comorbidity index 54 hypercholesterolemia 54 relapsed AML 54 vestibular dysfunction 54 renal function 54 ruboxistaurin 54 thrombocytosis 54 inotropes 54 hemodynamic instability 54 anticoagulation 54 GH deficiency 54 coronary revascularization 54 Critical limb ischemia 54 microvascular dysfunction 54 undergoing CABG 54 decompensated cirrhosis 54 secondary hyperparathyroidism 54 cardiovascular disease 54 liver transplant recipients 54 androgen deprivation 54 inotropic 54 Diabetic nephropathy 54 clinically localized prostate 54 anemias 54 NOMID 54 COPD exacerbation 54 patients undergoing CABG 54 prognostic indicators 54 biochemical recurrence 54 preoperative PSA 54 hepatic lesions 54 chemotherapeutic regimens 54 Torsades de Pointes 54 Pulmonary arterial hypertension 54 metastatic lung cancer 54 intracerebral hemorrhage 54 hyperphosphataemia 54 defibrillator implantation 54 REMICADE ® 54 Fluid retention 54 chronic renal disease 54 renal disease 54 intravesical therapy 54 statin therapy 54 myocardial infarction stroke 54 ventricular dysfunction 54 Sleep disturbances 54 oral antidiabetic medication 54 subtrochanteric 54 esophagogastric 54 fluid overload 54 systemic JIA 54 fibromyalgia syndrome 54 comorbid diagnoses 54 neurocognitive impairment 54 uncontrolled seizures 54 PTEN mutations 54 non metastatic osteosarcoma 54 vascular abnormalities 54 Left ventricular hypertrophy 54 severe renal impairment 54 preoperative chemotherapy 54 gallstone disease 54 Diabetic neuropathy 54 pulmonary infiltrates 54 perfusion abnormalities 54 posttransplant 54 mild renal insufficiency 54 neuropsychological impairments 54 abnormal vaginal bleeding 54 antidiabetic medications 54 airway hyperresponsiveness 54 reoperations 54 neurodevelopmental outcomes 54 pancreatic insufficiency 54 lymph node involvement 54 thymectomy 54 acid suppressive medication 54 reperfusion therapy 54 Radical prostatectomy 54 QTc intervals 54 status epilepticus 54 GnRH agonists 54 pancreatic adenocarcinoma 54 CHD CVD 54 diabetes hypertension 54 NSAID therapy 54 pre operatively 54 carotid plaques 54 renal tumors 54 peritumoral brain edema 54 BMI ≥ 54 polyarticular 54 cystic fibrosis chronic pancreatitis 54 pheochromocytoma 54 Bergenstal 54 dirucotide MBP# 54 left ventricular hypertrophy 54 hepatitis B infection 54 thromboembolism 54 receiving VELCADE 54 valvular heart 54 methotrexate therapy 54 impaired glucose metabolism 54 upper airway obstruction 54 etiologies 54 pediatric bipolar disorder 54 systemic amyloidosis 54 noncardiac 54 vertebral fracture 54 EBV infection 54 Brugada syndrome 54 acute myocardial infarction AMI 54 psoriatic arthritis PsA 54 postdischarge 54 diabetes hyperlipidemia 54 CVD mortality 54 induce orthostatic hypotension 54 prediabetes 54 ICD therapy 54 Testosterone deficiency 54 bioprosthetic valve 54 anemia neutropenia 54 myeloproliferative diseases 54 typical antipsychotics 54 sociodemographic variables 54 TAVR 54 antiepileptic medications 54 monoclonal gammopathy 54 atherosclerotic vascular disease 54 fasting glucose levels 54 Heavy menstrual bleeding 54 tuberous sclerosis TS 54 QTc prolongation 54 bisphosphonate therapy 54 testosterone supplementation 54 patientswith 54 diagnostic workup 54 chronic hepatitis cirrhosis 54 partial onset seizures 54 hypercalciuria 54 symptomatic paroxysmal AF 54 conventional angiography 54 riociguat 54 bone metastases 54 PAOD 54 VADT 54 mitochondrial toxicity 54 recurrent wheezing 54 acid suppressive therapy 54 heavily pretreated 54 cardioembolic stroke 54 chronic illness 54 PSADT 54 ejection fractions 54 biochemical abnormalities 54 MMSE scores 54 intracerebral haemorrhage 54 chronic pancreatitis 54 antimicrobial prophylaxis 53 coronary lesions 53 nonpharmacologic 53 nephropathy 53 generalized seizures 53 neurological complications 53 Morbid obesity 53 antiepileptic drugs AEDs 53 HbA 1c levels 53 disease progression 53 cytomegalovirus infection 53 COPD exacerbations 53 cerebral perfusion 53 acetabular fractures 53 multivariable analyzes 53 pulmonary resection 53 nontraumatic 53 HeFH 53 nondiabetic 53 hepatic insufficiency 53 dermatologic reactions 53 tachyarrhythmias 53 efalizumab 53 concomitant AEDs 53 Hurler syndrome 53 ACTOplus met 53 fibrotic disease 53 oral antidiabetic drugs 53 stenoses 53 temporal arteritis 53 myelofibrosis polycythemia vera 53 pharmacotherapies 53 candidemia 53 obstetric complications 53 stratifying patients 53 intima media thickness 53 upper gastrointestinal bleeding 53 diabetic complications 53 postoperative radiotherapy 53 cardiometabolic disorders 53 echocardiographic parameters 53 Pressure ulcers 53 PNH patients 53 CRBSI 53 transaminase levels 53 macular edema secondary 53 Heavy snorers 53 genetic polymorphisms 53 glitazones 53 aminotransferases 53 colorectal liver metastases 53 CHD mortality 53 prognostic markers 53 histologically confirmed 53 hypercoagulable 53 chronic hemodialysis 53 AUDs 53 HAART regimens 53 urolithiasis 53 hepatic function 53 intact parathyroid hormone 53 Lung transplantation 53 hypercalcemia 53 gastro esophageal reflux 53 ADPKD 53 pyelonephritis 53 renal scarring 53 NAbs 53 lung fibrosis 53 cardiac toxicity 53 affective psychoses 53 polypharmacy 53 pharmacologic treatments 53 postoperative infection 53 Diabetes mellitus 53 multivariate analyzes 53 subclinical disease 53 orthostatic hypotension 53 metabolic syndromes 53 OSAHS 53 aldosterone antagonist 53 dietary interventions 53 pain syndromes 53 unmeasured factors 53 glucose homeostasis 53 anti angiogenic agents 53 Insulin resistance 53 elevated ALT 53 myocardial infarctions 53 curative therapy 53 ischemic vascular 53 glycosylated hemoglobin HbA1c 53 cirrhosis liver failure 53 hyperlipidemia hypertension 53 ofpatients 53 diabetic nephropathy 53 coronary blockages 53 portal vein thrombosis 53 VUR 53 syndromal 53 acute STEMI 53 pharmacologic interventions 53 DMARDs 53 anticonvulsant drugs 53 decubitus ulcers 53 benign prostatic hypertrophy BPH 53 endometrial hyperplasia 53 endocrine abnormalities 53 systolic function 53 reflux disease 53 mixed dyslipidemia 53 OADs 53 varices 53 vWD 53 Genetic predisposition 53 von Willebrand disease 53 vesicoureteral reflux 53 neoplastic 53 oral hypoglycemic agents 53 SCr 53 chronic periodontitis 53 VAPRISOL 53 adrenal insufficiency 53 chronic obstructive lung 53 rhythm disturbances 53 IGFD 53 oral antidiabetes 53 coronary insufficiency 53 infective endocarditis 53 Logistic regression analysis 53 bacterial prostatitis 53 GBA mutations 53 Hashimoto thyroiditis 53 intermittent claudication 53 oral anticoagulant therapy 53 neurocognitive functioning 53 periprosthetic infection 53 antiplatelet therapy 53 breast abscesses 53 pramlintide 53 tumor necrosis 53 univariate analyzes 53 oxygen desaturation 53 Impaired Glucose Tolerance 53 daytime drowsiness 53 antidiabetic medication 53 Exclusion criteria 53 hyperphosphatemia 53 MMSE score 53 intravenous diuretics 53 QT prolongation 53 rheumatoid 53 INVEGA ® 53 laboratory abnormalities 53 MYCN amplification 53 hematological malignancy 53 vertebral compression fractures 53 disordered breathing 53 thyrotoxicosis 53 TMP SMX 53 terlipressin 53 acid suppressive medications 53 Vitamin B# deficiency 53 ESRD patients 53 serum calcium 53 cardiovascular hospitalization 53 antiemetics 53 EBRT 53 podiatric physician 53 hypokalemia hypomagnesemia 53 Multivariate analyzes 53 neuropsychiatric diseases 53 pharmacological therapy 53 PONV 53 antipsychotic prescribing 53 hemoglobinopathies 53 mealtime insulin 53 adrenal suppression 53 LQTS 53 genotypic resistance 53 antithrombotics 53 neurological abnormalities 53 arterial thrombosis 53 RLS symptoms 53 ventricular arrhythmias 53 malignant neoplasm 53 metformin monotherapy 53 resynchronization therapy 53 failure NYHA 53 coinfection 53 gastric adenocarcinoma 53 narrow QRS 53 choroidal neovascularization 53 statin medications 53 Parkinsonian symptoms 53 lipid lowering medications 53 dysfunctional voiding 53 atrioventricular block 53 noncardiovascular 53 sequelae 53 paclitaxel eluting stents 53 cardiomyopathies 53 urinary incontinence UI 53 intra abdominal abscess 53 atrial fibrillation atrial flutter 53 nephron sparing surgery 53 syncope 53 cachexia 53 inflammatory rheumatic 53 nephrolithiasis 53 hyperphenylalaninemia HPA due 53 cyclic HMB 53 Ivabradine 53 interferon ribavirin 53 gastrointestinal GI motility disorders 53 bronchopulmonary dysplasia BPD 53 osteoporotic vertebral compression fractures 53 Sarcopenia 53 prophylactic therapy 53 primary hypercholesterolemia 53 smoldering multiple myeloma 53 neutropenia dehydration dyspnea 53 untreated sleep apnea 53 antiepileptic drugs 53 liver dysfunction 53 catheter angiography 53 chronic HCV 53 CrCl 53 psychiatric disorders 53 infarctions 53 exacerbations 53 antiplatelet therapies 53 cSSSI 53 graft occlusion 53 prostate TURP 53 hemoglobin A1c levels 53 sulphonylureas 53 functional mitral regurgitation 53 malperfusion 53 intravenous cyclophosphamide 53 Adjuvant chemotherapy 53 risperidone Risperdal 53 paroxysmal atrial fibrillation 53 COPD 53 morbidity 53 nephrotoxicity 53 gastroenterology neurology 53 BENICAR HCT 53 ALI ARDS 53 Prehypertension 53 thrombocytopenic 53 metastatic bone 53 sleep apneas 53 revascularization procedure 53 essential thrombocythemia 53 baseline HbA1c 53 metabolic dysfunction 53 modifiable cardiovascular 53 lipoprotein levels 53 Complications Trial 53 arterial hypertension 53 antiangiogenic therapy 53 Stent thrombosis 53 immunosuppressant therapy 53 QTc interval 53 etiologic factors 53 tachyarrhythmia 53 nocturnal hypoglycaemia 53 type2 diabetes 53 cardiopulmonary diseases 53 rFVIIa 53 leukemia AML 53 carotid intima media 53 gastrointestinal bleeds 53 potassium sparing diuretics 53 liver resection 53 dysrhythmias 53 Overactive bladder 53 lipodystrophy 53 malabsorptive 53 hepatotoxicity 53 elevated creatinine 53 cardiac malformations 53 retransplantation 52 cognitively intact 52 myelofibrosis 52 advanced neoplasia 52 serum phosphorous 52 Atypical antipsychotics 52 cytopenias 52 impaired fasting glucose 52 hypopituitarism 52 transcatheter closure 52 Vertebral compression fractures 52 hsCRP levels 52 pulmonary toxicity 52 hemodilution 52 structural abnormalities 52 potential confounding variables 52 pancreatectomy 52 chronic eosinophilic leukemia 52 S. aureus infection 52 untreated celiac disease 52 antithrombotic therapies 52 secondary efficacy endpoints 52 intravascular hemolysis 52 phosphate binders 52 pharmacological intervention 52 liver metastasis 52 amnestic MCI 52 pharmacokinetic interaction 52 serum vitamin D 52 curative therapies 52 atherosclerotic coronary 52 renal toxicity 52 transaminase elevations 52 glycemic control 52 hyperinsulinemia 52 Temporal lobe epilepsy 52 ventricular tachyarrhythmia 52 reflux disease GERD 52 chronic noncancer pain 52 myocardial infarction MI 52 NYHA functional class 52 either acutely decompensated 52 Thyroid nodules 52 knee OA 52 multidrug resistant organisms 52 mycophenolate mofetil 52 Hip fracture 52 degenerative neurological diseases 52 Pioglitazone 52 AA Amyloidosis 52 hepatic impairment 52 EDARBI 52 proliferative retinopathy 52 obstructive jaundice 52 visilizumab 52 serum lipid levels 52 heterotaxy 52 congenital anomalies 52 MULTAQ 52 NYHA Class III 52 intracranial stenosis 52 abnormal Pap smears 52 vasculopathy 52 gastrointestinal GI bleeding 52 intravenous bisphosphonates 52 NPH insulin 52 prodrome 52 immunocompromised individuals 52 cytogenetic abnormalities 52 Acute Coronary Syndromes ACS 52 hemorrhagic cystitis 52 constipation OIC 52 vasogenic edema 52 pulmonary embolism PE 52 EDSS scores 52 deCODE Glaucoma TM 52 onset atrial fibrillation 52 femoral neck fractures 52 neovascular diseases 52 Mood disorders 52 cervicitis 52 Rh incompatibility 52 histologies 52 Thiazolidinediones 52 mildly symptomatic 52 bradycardia 52 breast endometrial 52 arterial stiffness 52 angioplasty stenting 52 metformin sulfonylurea 52 chemoprevention trials 52 antiarrhythmic drugs 52 generalized tonic clonic seizures 52 Carotid endarterectomy 52 invasive candidiasis 52 gastric atrophy 52 euthymic patients 52 antireflux surgery 52 hematopoietic cancers 52 relapsed ALL 52 diabetic hypertensive 52 dose atorvastatin 52 virologic failure 52 EGFR inhibitors 52 Opportunistic infections 52 juvenile myoclonic epilepsy 52 nocturnal hemodialysis 52 ocular disorders 52 CMV infection 52 LAGB 52 systemic lupus erythematosus SLE 52 surrogate markers 52 fulminant hepatitis 52 stimulant medications 52 insulin glargine 52 CYPHER Stent 52 R0 resection